Titan Pharmaceuticals Inc Cash Flow Quality Index
Titan Pharmaceuticals Inc cash flow quality index. Titan Pharmaceuticals Inc (TTNP) has a Cash Flow Quality Index of 1.13x as of June 2016. Operating cash flow of $13.51 Million exceeds net income of $11.93 Million, indicating high earnings quality where cash backs reported profits. See TTNP FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Titan Pharmaceuticals Inc (1997–2016)
Cash flow quality index of Titan Pharmaceuticals Inc from 1997 to 2016. Historical Cash Flow Quality Index for Titan Pharmaceuticals Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore TTNP operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Titan Pharmaceuticals Inc Cash Flow Quality Index by Year (1997–2016)
Titan Pharmaceuticals Inc cash flow quality index by year from 1997 to 2016. Year-by-year earnings quality comparison for Titan Pharmaceuticals Inc. For the full cash flow conversion analysis, see TTNP cash generation efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2016 | 1.23x | $6.29 Million | $5.13 Million | ▲ +221.5% |
| 2013 | -1.01x | $-9.80 Million | $9.71 Million | ▼ -108.5% |
| 1997 | 11.83x | $7.10 Million | $600.00K | — |